Twenty-four-hour urinary losses of leptin in CAPD patients were negligible, accounting for 5.6±1.8% Background. To determine whether serum leptin concentrations in patients undergoing continuous ambu-(range 0.3-15.2%) of total (peritoneal and urinary) loss of this hormone. latory peritoneal dialysis (CAPD) are influenced by peritoneal loss of leptin and to compare serum leptin Conclusions. These findings suggest that serum leptin levels are not affected by continuous peritoneal loss of levels of normal subjects with those of patients receiving renal replacement therapy such as haemodialysis leptin during CAPD and that insulin resistance and hyperinsulinaemia contribute to elevated serum leptin (HD), CAPD, or kidney transplantation. Subjects and methods. Eighty-four individuals were concentrations in CAPD and HD patients. The aetiology of increased serum leptin levels in kidney transinvestigated: six females and 14 males on standard CAPD; 13 females and 13 males on chronic HD; 10 plant recipients is probably different from that in dialysis patients. female and eight male kidney transplant recipients, and 10 female and 10 male subjects as controls. Morning serum, 8-h and 24-h samples of peritoneal Key words: b 2 -microglobulin; body mass index; haemofluid concentrated to 6-20-fold by Centricon 3 (cutoff dialysis; insulin; kidney transplantation; leptin; periton-3000 daltons), and 24-h urinary concentrations of eal dialysis; peritoneal loss; residual renal function leptin were measured with commercial RIA (Linco Research, Inc., USA). Venous blood and peritoneal fluid samples of albumin, b 2 -microglobulin, glucose, urea, and creatinine were determined by standard Introduction laboratory techniques. Serum insulin levels were measured by radioimmunoassay. Leptin is a 16-kDa plasma protein that is encoded by Results. Patients (men and women) on CAPD and the ob gene [1], synthesized in adipocytes and play an after kidney transplantation exhibited significantly important role in regulation of food intake and energy higher serum concentrations of leptin and leptin/BMI expenditure in animal models [2, 3] . The role of this ratios than control subjects. These increased values did hormone in humans is still unknown. However, in not reach statistical significance in HD patients. Serum most of the clinical studies very significant positive leptin concentrations were correlated very significantly correlations were demonstrated between serum leptin with BMI in all cases (r=0.380, P<0.001). Moreover, concentrations and body mass index (BMI ) or body in CAPD patients (r=0.630, P<0.007) and in HD fat mass [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15]. Leptin in humans is partly cleared by patients (r=0.668, P<0.005), but not in kidney trans-the kidney [16,17]. Therefore, it is not surprising that plant recipients or control subjects, significant correla-increased plasma leptin concentrations in patients with tions were observed between serum leptin and insulin chronic renal failure (CRF ) pre-dialysis [4-6 ], during concentrations. Residual renal function (RRF ) in the haemodialysis [4, 5, 7, 8, 16,18] or peritoneal dialysis range 0-12.8 ml/min and serum b 2 -microglobulin levels [4, 6, 7] and after kidney transplantation [7] have been in the range 7.9-47.1 mg/l did not influence serum reported. However, there was no significant correlation leptin levels in CAPD and HD patients. As expected, between serum leptin levels and residual renal function leptin was detected in the peritoneal fluid of (RRF ) [4, [6] [7] [8] 18]. CAPD patients. Twenty-four-hour peritoneal loss It has been suggested that elevated serum leptin (30.95±21.05 ng/min) and 24-h peritoneal clearance concentrations in CRF are related to insulin resistance (0.01±0.01 ml/kg/min) of leptin account for only 3.9% and hyperinsulinaemia [5] and that serum leptin conof estimated whole-body leptin production rate and centrations could serve as a valuable clinical marker 0.7% of leptin clearance from plasma respectively. for the body fat content [4] .
(b 2 MG) were measured in the IMX system (Microparticle of leptin could also influence the serum levels of this Enzyme Immunoassay, Abbott Laboratories, Abbott Park, low molecular weight protein.
IL, USA). Serum insulin concentrations were measured by
The aim of the present study was to evaluate the radioimmunoassay.
effect of peritoneal loss of leptin on serum levels of 
Subjects and methods
The Mann-Whitney test was used for analysis of leptin values. Eighty-four individuals were investigated: six female and 14 male undergoing standard CAPD receiving four exchanges of 2 litres of dialysis fluid (Dialine 1.5% dextrose; Travenol Labs., Ashdod, Israel ) per day; 13 female and 13 male Results haemodialysis patients (HD) receiving three sessions of 4-h haemodialysis per week, using bicarbonate-buffered dialysate Both CAPD and kidney transplant patients exhibited and cellulose acetate dialysers; 10 female and eight male significantly higher serum concentrations of leptin and kidney transplant recipients ( Tr) receiving triple immunoleptin/BMI ratios than control subjects ( Tables 2 and   suppressive therapy with varying daily doses of azathioprine (range 75-125 mg), cyclosporin (range 100-250 mg), and 3). These increased values did not reach statistical prednisone (range 7.5-10 mg); 10 female and 10 male normal significance in HD patients. As shown in Table 4 , subjects as controls. The CAPD and HD patients were serum leptin concentrations correlated very significreceiving recombinant human erythropoietin in similar doses antly with BMI in all studied individuals. Moreover, (females, 81.4±17.8 and 172.9±68.3; males, 76.0±19.3 and in CAPD and HD patients, significant correlations 90.7±23.3 respectively; mean±SEM U/kg/week). The clin-were observed between serum leptin and insulin conical characteristics of the studied individuals are shown in centrations ( Figure 1 ). These correlations did not reach Leptin was detected in the peritoneal fluid of CAPD Venous blood was sampled at 0800 hours after 12 h of patients. Twenty-four-hour peritoneal loss and 24-h fasting; 24-h and 8-h (overnight) samples of peritoneal peritoneal clearance of leptin estimated in 11 male dialysate and 24-h urine samples were collected. Serum and patients on CAPD were 30.95±21.05 ng/min and dialysate concentrations of glucose, urea and creatinine were 0.01±0.01 ml/kg/min respectively. ( Table 5 ). These results fit the log-to-log function: ln (molecular mass)=9.47-0.79 ln (peritoneal clearance) with correlation coefficient (r) 0.999, and suggest that The major new finding of this study was the detection of leptin, a protein of MW 16 kD, in urine and The present results corroborate previous studies [4, 6, 7] , which demonstrated that CAPD patients and kidney transplant recipients exhibited significantly higher serum leptin levels and leptin to BMI ratios than control subjects. In contrast to some studies published recently [5, 7, 8, 16 ] , HD patients showed serum leptin concentrations and leptin/BMI ratios in the high-normal range. One possible explanation for these discrepant results may be the fact that HD patients were older than control subjects. Two studies have shown that serum leptin concentrations are inversely correlated to age [14, 15] showing a reduction in circulating leptin by 53% in subjects over age 60 years [14] . In addition, suppression of leptinaemia induced by long-term recombinant human erythropoietin therapy in haemodialysed uraemic patients has 20 kg/m2, Kennedy et al. [26 ] found that serum concentrations of leptin were similar in men and in women. The percentage of these patients in our previously reported. We found that peritoneal loss of leptin accounts for only 3.9% of mean estimated population was only 10.7% with similar distribution among the groups. Therefore, in accordance to the whole-body leptin production rate and 0.7% of mean leptin clearance from plasma when these results were results reported by others [2, 3] , women in this study had values for leptin markedly higher than men, compared with the results estimated in 14 male volunteers [22] . There are no previous reports about suggesting specific gender-related and/or hormonal effects [27, 28] . whole-body production rate and plasma clearance of leptin in uremic patients. A preliminary report show-BMI is a relative marker of obesity and percent of body fat mass [29] . In confirmation with previous ing down-regulation of the ob gene expression in CAPD patients with hyperleptinemia [23] suggests observations [7] [8] [9] [10] 30] , we found a strong positive correlation between serum leptin concentrations and that these parameters in uremic patients may differ from those of healthy subjects. 24-h urinary losses of BMI in individuals of all studied groups.
A long-term effect of insulin on leptin production leptin were also very small, accounting for 5.6% of mean total (peritoneal plus urinary) loss of this has been demonstrated both in vitro and in vivo [31] .
High leptin concentrations may in part be influenced hormone. These findings indicate that peritoneal and urinary losses of leptin have only a small or negligible by hyperinsulinaemia or impaired insulin sensitivity [30] . The significant association described between effect on serum leptin concentrations in CAPD patients. The strong positive correlation between fasting plasma levels of leptin and insulin is independent of body adiposity [32] . On the other hand, leptin serum values and peritoneal loss of leptin also points to passive leakage of this low molecular weight attenuates some insulin-induced signals in human hepatic cell lines raising the possibility that leptin moduprotein from blood into peritoneal fluid. As expected [19] , transperitoneal transport of leptin, together with lates insulin activities in obese individuals [33] . Insulin resistance and hyperinsulinaemia are well-known feaalbumin and b 2 MG, was strongly correlated with molecular mass (r=0.999). These kinetic parameters tures of chronic renal failure (CRF ) [34, 35] . Stenvinkel et al. [5] showed first that insulin resistance and suggest that peritoneal transport of leptin is unlikely to occur in the form of a complex between leptin and hyperinsulinaemia contribute to elevated serum leptin concentrations in CRF patients. We extended this its binding proteins [21] and that concentrations of leptin in peritoneal fluid are not due to its degradation observation to patients undergoing HD and CAPD, in whom insulin levels correlate with serum leptin or intraperitoneal production by adipocytes. Alternatively the expected decreased peritoneal clear-concentrations.
Our findings are in agreement with the results of ance of leptin from plasma due to protein binding [21] may be balanced by the local intraperitoneal Howard et al. showing markedly elevated serum concentrations of leptin in kidney transplant recipients synthesis of leptin by omental adipocytes [24] .
The absence of significant positive correlation [7] . Serum leptin concentrations in transplant subjects were affected by adiposity (BMI ) but not by fasting between serum levels and urinary loss of leptin in CAPD patients support the conclusions of Meyer insulin levels or kidney function. The role of steroid treatment in the increase of leptin levels in these et al. [17] that renal leptin removal from plasma is due to renal tissue leptin uptake and degradation patients has not been excluded. Indeed, steroids have been found to increase leptin mRNA expression and rather than glomerular filtration and urinary excretion.
protein production by adipocytes in vitro [36 ] and in 15. Ryan AS, Elahi D. The effects of acute hyperglycemia and vivo [37] . However, recent evidence in patients with hyperinsulinemia on plasma leptin levels: its relationship with Cushing's syndrome point to a predominant role of body fat, visceral adiposity, and age in women. J Clin Endocrinol impaired insulin sensitivity as the major determinant 
